© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The story of boldine begins in the forests of South America, where the boldo tree, Peumus boldus, earned its place among medicinal plants long before its active alkaloid became a subject of laboratory study. Early botanists in the nineteenth century isolated boldine as a crystalline compound, fascinated by its alignment with folk remedies and curious about its range of action. Word of these findings spread to chemists in Europe. As scientific exploration continued, boldine drew increasing attention not just for its botanical origins but for chemical complexity and possible health implications. Over decades, analytical techniques such as NMR and mass spectrometry helped clarify boldine’s molecular structure. Early studies often failed to draw a straight line between traditional use and clinical evidence, but boldine stayed in the conversation because every experiment added one more brushstroke to the portrait of this alkaloid. The push for quality control grew, especially as global commerce began to move more herbal ingredients across borders.
Boldine stakes its claim in both research labs and in the natural products market. It is known as an aporphine alkaloid derived mainly from the leaves and bark of boldo trees. Numerous extraction protocols exist, with both small-scale artisanal batches and larger, semi-industrial processes using ethanol or methanol as solvents. Commercial boldine may appear as a fine, yellowish crystalline powder. Extracts containing boldine sometimes find their way into dietary supplements, although standardization remains spotty. Botanists, chemists, and formulators value its role as a model molecule in plant chemistry studies.
Boldine stands out for its distinctive yellow-green color in its pure form, and its slight bitterness makes it easy to identify by taste for those who work with it. It exhibits limited solubility in water but dissolves more readily in alcohols. Its structure is marked by the presence of methoxy and hydroxyl groups, features that influence both its reactivity and its apparent antioxidant activity. The molecular formula, C19H21NO4, gives it a modest molecular weight—light enough for smaller-scale chromatography but heavy enough to present some challenges in crystallization. While boldine remains stable under standard conditions, exposure to strong acids and bases can prompt degradation or even structural rearrangement.
Any product carrying the boldine name ought to bear a purity rating. In the best circumstances, the label provides a guarantee based on HPLC or TLC results, with reputable suppliers ensuring traceability of raw material, batch numbers, and country of origin. Labels also frequently include the CAS number, 476-70-0, along with standard storage temperature and shelf-life recommendations. Reliable suppliers support these claims with certificates of analysis, but consumers and researchers often encounter poorly documented extracts in supplement markets. Without clear transparency, questions of adulteration and misidentification start to crowd out good science.
Most boldine comes from an extraction process using the leaves or bark of Peumus boldus. Harvested plant material dries under controlled conditions, then gets powdered and soaked in an ethanol or methanol solution. After filtration, the mixture goes through evaporation and successive purification steps. Crude extracts require further treatment to isolate boldine itself, and chromatographic separation helps raise purity from a few percent to over ninety. Some processes favor eco-friendly solvents and avoid high temperatures to prevent unwanted decomposition. Researchers may use synthetic routes, but challenging reaction conditions and lower yields usually keep these methods within the domain of academic studies rather than mass production.
Boldine presents an engaging platform for chemical modification. The phenolic and methoxy groups invite selective reactions, including methylation and acetylation. Oxidative derivatization has produced analogs for structure-activity relationship studies, hoping to link subtle structural changes to shifts in pharmacological behavior. While the parent molecule offers a starting point for antioxidant evaluation, researchers often want to nudge its solubility or metabolic stability either through minor tweaks at reactive positions or by coupling with small side-chains. This iterative work reflects the slower pace of translating plant alkaloids into therapeutics—a field that rewards patience and chemical insight.
In the literature and on labels, boldine sometimes appears under synonyms like N-methyl-1,2,9,10-tetrahydro-benz[d,e]isoquinoline or 2,9-Dihydroxy-1,10-dimethoxyaporphine. These alternative names can tangle researchers in knots unless manufacturers clearly cross-reference both chemical and commercial language. Products referencing ‘boldo leaf extract’ often contain varying amounts of boldine, a situation that blurs the line between pure substance and crude botanical mixture. Some supplement makers have coined branded formulations, but the smart consumer looks for standardized extracts backed by third-party tests.
No matter how long a substance like boldine has been part of traditional use, working safely means more than honoring history. Laboratory guidelines highlight the need for gloves, eye protection, and adequate ventilation during handling. Bulk forms, especially dusty powders, pose inhalation risks and may cause irritation if skin or eyes make contact. National and international safety frameworks call for specific waste disposal methods to keep chemical runoff out of water systems. Every researcher or technician must keep up to date with changes in safety regulations, especially when protocols develop faster than published literature.
Boldine continues to draw researchers interested in oxidative stress, cell signaling, and metabolism. Its antioxidant potential crops up regularly in studies exploring neurodegenerative disorders, hepatic protection, and cardiovascular health, but results vary widely depending on dose, purity, and study design. A few years of following the literature reveals surges of enthusiasm, then a cooling-off as unanswered questions pile up. The molecule’s bitter taste complicates efforts to include it in food or beverage formulations. In some countries, regulatory bodies have slowed widespread application by limiting approved uses and requiring more comprehensive safety documentation. For now, boldine lives mainly in the realm of in-vitro and animal studies, with only occasional breakouts into commercial health products.
Boldine surfaces in research circles focused on natural antioxidants and plant-derived therapeutics. Publicly funded projects and university-led groups have reported findings on its ability to modulate enzymes such as xanthine oxidase and cholinesterase, as well as its impact on insulin resistance models. Industry partnerships sometimes drive progress, but without consistent investment from pharmaceutical firms, most breakthroughs remain on preclinical territory. Methodological challenges abound: inconsistent extraction methods, questions about bioavailability, and a persistent gap between in vitro potency and in vivo outcomes. Networking among academic labs can help build momentum, but commercialization hinges on better data addressing absorption, metabolism, and long-term safety.
Anyone working with natural products develops a healthy respect for both their promise and their pitfalls. Boldine’s toxicity profile remains only partly clarified. Older studies flagged signs of gastric irritation and liver fluctuation at higher doses. More recent research casts its overall safety in a more favorable light, especially in controlled, moderate exposures, but caution persists about chronic use or combination with other drugs. Researchers continue to monitor for potential mutagenicity and allergenicity. No consensus has formed on a safe upper limit for long-term supplement use, and regulators have responded with caution. Anecdotal evidence sometimes gets outsized attention, but clear, peer-reviewed studies with large, diverse populations would help clarify the picture.
Boldine’s road ahead depends on its ability to answer persistent questions about bioactivity, safety, and application. Research infrastructure has improved—LC-MS and high-throughput screening have replaced older methods—yet the leap from cell culture to clinical relevance remains rocky. If boldine finds a niche as either a pharmaceutical lead compound or as a specialty nutraceutical, such progress will result from partnerships across botanical science, pharmacology, and regulatory law. Increased transparency in sourcing and manufacturing, coupled with high standards in clinical research, may build the evidence base needed to move boldine out of academic journals and into broader practical use. Growing consumer skepticism about unproven plant-based claims challenges anyone marketing boldine-based products. Tackling these hurdles will take both rigorous science and honesty about the limits of what current data show.
Boldine is a chemical found in the leaves and bark of the boldo tree, which grows mostly in parts of Chile and Peru. If you’ve ever wandered into a store selling South American herbal teas, you might’ve seen boldo listed among the blends promising relief for all sorts of digestive problems. The truth is, people in that part of the world have used boldo for hundreds of years, especially for calming stomach pain and fighting off liver complaints. What makes boldine stand out is its naturally bitter taste. That bitterness actually comes from the compound itself, which is what gives boldo its reputation as a natural remedy.
Today, interest in boldine goes beyond folk tradition. Scientists have looked into the molecule and found a few reasons to pay attention. Boldine acts as an antioxidant, which means it helps keep cells from being damaged by free radicals. Whenever I read studies showing how antioxidants help out with chronic illnesses or even slow certain signs of aging, it’s a good reminder that plants still have a lot to offer, even in a world filled with high-tech medicine. There’s evidence boldine reduces inflammation—not just in the gut, but possibly in the liver, blood vessels, and even some parts of the brain.
Liver health, especially, draws a lot of interest. Liver disease continues to impact millions worldwide, whether linked to alcohol, viral infections, or fatty liver driven by modern diets. Boldine has shown promising effects in animal models and a handful of early human trials for keeping liver enzymes in check and protecting against drug or toxin overload. Boldo leaves, rich in boldine, show up in herbal teas and sometimes in supplements marketed to those wanting to protect their liver or ease bloating and indigestion.
Boldine’s benefits need honest perspective. Scientists still debate the right dosage and how much works without causing other problems. For some people, especially those with pre-existing health problems or who take medications for their liver, kidneys, or blood pressure, boldine could cause interactions. There’s also a risk with overconsumption, since unregulated supplements and teas do not always list exact concentrations. Based on experience reading clinical data and talking with people using herbal remedies, I often remind them to check ingredients, talk with a healthcare professional, and avoid high doses just because something is “natural.”
Research transparency matters here. One study alone never tells the whole story, especially when money and hype get involved in the supplement industry. Reliable research should be peer-reviewed, run with honest controls, and regularly updated to catch possible side effects or new applications. Boldine looks promising, but it doesn’t replace medical treatment for liver issues or chronic health problems.
Boldine’s biggest value might lie in the ongoing shift toward more plant-based remedies and wellness tools. As drug resistance and liver illnesses rise, people look for gentle options rooted in tradition but supported by science. By focusing on honest research, transparent sourcing, and practical advice, boldine could fit into modern health routines. Companies and researchers working with boldine have a responsibility to keep things safe, clear, and verifiable—not just sell another quick-fix pill.
Boldo tea won’t suddenly cure decades of liver strain or replace a healthy lifestyle, but its key molecules, including boldine, shine a light on how nature and science can sometimes team up for better outcomes.
Boldine comes from the bark of the boldo tree, found mainly in South America. For generations, people have used boldo leaves as a remedy for digestive issues, liver complaints, and even as a general tonic. The main thing in boldo that gives it these effects is called boldine. In recent years, boldine caught attention as an antioxidant. Researchers have been studying its ability to balance oxidative stress, which plays a role in heart, nerve, and liver health.
Doctors and scientists have run several lab and animal studies looking at how boldine works. They found that the compound has antioxidant power, and it may help with inflammation or protect certain organs. At the same time, these studies also check for any harm that could come from using too much. In most animal research, low doses over short periods did not show significant toxic effects. But it’s important to note that these studies rarely last long, and they use animals, not people.
A handful of research papers point out that boldine at high concentrations can upset liver function or cause changes in blood chemistry. There’s not enough strong evidence yet about how safe it is for long-term use or in people with chronic illnesses. Human research remains very limited. Until clinical trials run by qualified teams come out, the bigger picture on safety stays murky.
People who use supplements or herbal teas with boldine sometimes notice stomach cramps, loose stools, or mild nausea. There are case reports that mention skin reactions like itching or rashes. The boldo leaf itself carries small amounts of ascaridole, a compound that can be toxic if taken in large amounts, especially for children or pregnant individuals. Folks with liver disease or bile duct blockages have a higher risk for negative effects because boldine and related substances process through the liver.
Drug interactions pose another problem. Boldine might affect how the body clears medicines broken down in the liver, possibly making side effects from those medicines worse or lessening their effect. For someone taking regular prescriptions, this matters a lot.
Herbal remedies feel natural, but natural doesn’t always mean safe. Traditional use provides clues, yet today’s supplements often come in higher doses or purer forms than people would ever get from drinking tea made from leaves. My own relatives pick herbs from the garden, but the amounts stay small, and use happens with care—no one swigs a bottle of plant extract. This sense of balance gets lost with mass-produced pills and powders.
A responsible approach starts with asking a qualified health professional before taking boldine, especially for anyone managing health conditions or taking regular medications. Keep an eye out for unexpected reactions and stop using it if problems come up. Buying from reputable sources reduces the risk of contamination or mislabeled ingredients.
Quality matters as much as dosage. Companies that share lab results and source information help buyers spot safer products. If someone tries boldine, start at the lowest possible dose and track how it feels day by day. Watch for digestive upset, skin problems, or drug interactions, then discuss with a pharmacist or medical provider.
Researchers need to run careful, well-designed clinical trials in people to spell out both short-term and long-term risks. Until science catches up, using boldine comes down to personal responsibility, clear communication with healthcare teams, and putting safety above hype. The old saying about the dose making the poison still rings true—a little may help, too much may harm, and knowing the difference saves headaches or worse.
Boldine comes from the boldo tree, a hardy plant native to South America. Some see it as a promising natural compound—often pointed to for its antioxidant properties. Curiosity keeps growing about how boldine might help with liver support, inflammation, and even as an ingredient in novel therapies. Patients, researchers, and supplement companies have all shown interest, but not every use is backed by strong clinical trial data.
Those looking for boldine usually start by searching online. Many supplement websites and chemical suppliers post listings for it. Yet, boldine doesn't end up on the shelves at big chain pharmacies—at least not in its pure, isolated form. Health food stores sometimes offer boldo leaf extracts, and these contain boldine among other compounds, but pure boldine remains less common. Some global chemical supply companies, such as Sigma-Aldrich or TCI, offer pure boldine for laboratory use—usually in small quantities, and almost always under strict conditions about usage and shipping.
People in search of boldine need to keep quality and safety in mind. Regulatory agencies do not approve boldine as a dietary supplement everywhere, which turns its sale into a complicated patchwork. Many online listings lack third-party testing or clear certificates of analysis. There have been cases where advertised products did not match the actual compound inside the container. Trustworthy suppliers should provide identity and purity documentation, batch analysis, and transparent sourcing details. In my experience, hunting for pure compounds on unregulated platforms brings more risk than reward. I've seen researchers struggle with counterfeit or contaminated material, setting back their studies and wasting their budgets.
Boldine is not an FDA-approved medication or supplement in the United States. Other countries treat it in similar fashion. Laboratories may purchase it for studies, but private buyers should know local laws before importing pure compounds. Customs can flag imported material without clear labeling, and penalties can be stiff. If a supplement company markets boldine in health claims, the Federal Trade Commission and FDA could step in if the claims get exaggerated or prove outright false. It’s not unheard of for companies to pull such products off the shelf after facing pressure from regulators.
Reputable chemical supply companies provide detailed documentation you can verify. Look for companies publishing third-party test results, preferably from ISO-certified labs. Many require proof of your lab affiliation or research institution before selling pure boldine. Supplement products with vague ingredient lists or grand health claims deserve extra scrutiny. My own rule: if a company dodges questions about purity, walk away.
For those not working in a laboratory, sticking with boldo leaf teas and standardized extracts from established wellness brands offers more peace of mind. Safety studies on whole herb extracts stretch further than on isolated boldine. Reading independent reviews and consulting clinical pharmacists also brings clarity. Taking unapproved isolated compounds, especially from uncertain sources, carries clear risks that can outweigh the promise. Until bolder human trials give clearer answers about dosing, safety, and benefits of isolated boldine itself, focus on whole products vetted for purity by third parties.
Curiosity about boldine usually comes from folks interested in natural supplements or those searching for ways to manage oxidative stress. The compound comes from the Peumus boldus tree, and traditional medicine turned to it for liver health and digestive issues. These days, plenty of supplement brands list boldine as an active ingredient, but folks rarely find clear dosage instructions. That gap in information raises important questions about safety, effectiveness, and trust.
Research shows boldine has antioxidant properties, making it attractive for people wanting to protect cells from damage. Animal studies often land on doses ranging from 1 to 10 mg per kilogram of body weight, usually given to lab rats and mice. Human data is not just thin — it’s almost nonexistent. Without strong clinical evidence, the recommended dosage for people just doesn’t exist in reputable literature.
Some supplement manufacturers suggest anywhere from 1 mg to 100 mg per serving. Without regulated guidelines, this is more guesswork than medical advice. Medical professionals and organizations have yet to publish a standard dose for humans, which creates room for error. In the real world, this means standing at the supplement aisle and weighing tempting promises against the risk of potential side effects.
Taking a supplement without understanding the dose is a risky bet. The liver processes compounds like boldine, and too much can strain the very organ a person might want to protect. High doses could lead to stomach upset, dizziness, or even worsen pre-existing conditions. People taking medications—like those for blood pressure or diabetes—face an extra layer of concern, as boldine can interact with these drugs.
Relying on animal studies or supplement packaging for dosage information isn’t enough. In my own conversations with healthcare providers, the refrain is clear: without large, peer-reviewed clinical trials, any dose recommendation amounts to speculation. Personal experience only highlights how easy it is for misinformation to travel, especially online, where unverified sources often outrank reliable ones.
If someone feels drawn to boldine, consulting with a healthcare provider beats guessing every time. Doctors and pharmacists bring years of training and know how to weigh the benefits and risks based on real health needs. A transparent conversation means figuring out if boldine has a place in someone’s routine—or if the risks outpace the rewards.
Supplement manufacturers should back up their products with clear, evidence-based information. Trust builds in a marketplace where transparency rules and regulators step in when companies sidestep the rules. Researchers who focus on human trials of boldine could help fill gaps in our collective understanding and provide guidance rooted in real data.
Until science catches up, the best approach mixes skepticism with caution. Many people see supplements as harmless because they come from plants, but that mindset overlooks the power these compounds can carry. Clarity on boldine dosage remains elusive, and for now, medical guidance stands as the best compass.
Boldine, a plant alkaloid found mainly in the boldo tree, has drawn interest for its potential antioxidant and liver-protecting abilities. People turning to natural supplements sometimes notice boldine in teas or capsules, expecting it to help with digestion, oxidative stress, or general well-being. Pharmacists and doctors ask about herbal and plant-based remedies because the world likes to mix old wisdom with new science.
Combining plant extracts with medication has real risks. Research on boldine itself remains limited compared to common drugs or herbs such as St. John’s Wort or grapefruit. Yet, animal and cell studies hint that boldine could affect how bodies process certain medicines. The main path for concern centers on how the liver works. The liver uses enzymes, especially the cytochrome P450 system, to process and clear drugs. Early studies, including work shared in Chemico-Biological Interactions and Frontiers in Pharmacology, show that boldine can tweak the activity of some of these enzymes.
If a supplement like boldine changes how these enzymes work, the levels of common medications in the bloodstream could shift—sometimes dangerously. Faster breakdown means less effect, and slower breakdown can lead to side effects. Medications for cholesterol, certain antidepressants, blood thinners, and some chemotherapy drugs all travel through these liver pathways. No one wants a natural supplement to undercut a life-saving prescription.
My own time as a pharmacy technician showed plenty of people treat supplements as harmless—like herbal teas in the kitchen. One patient, juggling blood pressure pills and a cocktail of health-store products, landed in the emergency room due to unexpected swings in medication levels. This happened even without boldine, but the logic applies widely: the supplements aren’t always as innocent as they seem. Most health professionals want to know the “full list” for this reason.
Boldine’s popularity stays low, so detailed clinical data remains sparse. That doesn’t mean the risk vanishes. Fewer studies don’t always mean greater safety; it just means people haven’t checked as carefully. European specialists have raised alarms about potential liver and kidney effects based on animal research—especially when doses rise. For individuals already managing complex medication schedules, such as transplant patients or those using anti-epileptics, caution isn’t paranoia; it’s common sense.
Solutions center on better communication and research. Health providers need open talks with patients about all the pills, powders, and teas in the cupboard. Until science catches up, pharmacists and physicians must lean on known mechanisms, even if human data is thin. Regulators and supplement makers need tighter guidelines and clear labeling. If manufacturers commit to robust ingredient testing and research, trust grows on all sides.
If you think about adding boldine or any new supplement to your routine, check in with your healthcare provider. List every medication and supplement at appointments, not just the prescription ones. Watch for changes: anything from strange bruising, tiredness, or stomach upset might matter. Stay skeptical of bold claims backed by little evidence, and keep conversations honest. The world of drug-supplement interactions changes fast, and nobody should gamble with their health.
| Names | |
| Preferred IUPAC name | (7aR)-2,9-dihydroxy-1,10-dimethoxy-7,7a-dihydro-6H-dibenzo[de,g]quinolin-6-one |
| Other names |
Boldo camphor Boldoine |
| Pronunciation | /ˈbɒl.daɪn/ |
| Identifiers | |
| CAS Number | 476-70-0 |
| Beilstein Reference | Beilstein Reference: 2058813 |
| ChEBI | CHEBI:3238 |
| ChEMBL | CHEMBL218950 |
| ChemSpider | 2157 |
| DrugBank | DB04250 |
| ECHA InfoCard | 07c23b97-9f7c-4623-b0c7-a7c3d85ba3f9 |
| EC Number | 3.1.1.18 |
| Gmelin Reference | 10455 |
| KEGG | C09745 |
| MeSH | D01.268.655.436.100 |
| PubChem CID | 73000 |
| RTECS number | CB4150000 |
| UNII | W9K5T4I25A |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C19H21NO4 |
| Molar mass | 327.39 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | D: 1.355 g/cm3 |
| Solubility in water | slightly soluble |
| log P | 0.81 |
| Vapor pressure | 0.000083 mmHg at 25°C |
| Acidity (pKa) | 7.12 |
| Basicity (pKb) | 5.14 |
| Magnetic susceptibility (χ) | -95.0 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.634 |
| Viscosity | Viscosity: 80-120 cP |
| Dipole moment | 3.21 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 329.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -247.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6107 kJ/mol |
| Pharmacology | |
| ATC code | A11GB |
| Hazards | |
| Main hazards | Suspected of causing genetic defects. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07", "GHS08 |
| Signal word | Warning |
| Hazard statements | Hazard statements: H302, H312, H332 |
| Precautionary statements | Keep out of reach of children. Read label before use. If medical advice is needed, have product container or label at hand. |
| Flash point | 122 °C |
| Autoignition temperature | Autoignition temperature: 420 °C (788 °F; 693 K) |
| Lethal dose or concentration | LD50 (mouse, intravenous): 20 mg/kg |
| LD50 (median dose) | LD50: 500 mg/kg (rat, oral) |
| NIOSH | Not assigned |
| PEL (Permissible) | 0.2 mg/m3 |
| REL (Recommended) | '0.2 – 5 mg/kg' |
| IDLH (Immediate danger) | IDLH not established |
| Related compounds | |
| Related compounds |
Coclaurine Apomorphine Glaucine |
